TRAQ offering is now closed and is no longer accepting investments.
INVEST IN TRAQ TODAY!
Your next-generation fitness, health & wellness tracker. Own Your Health™.
$327,225.98 Raised
REASONS TO INVEST
Growing Market: The total addressable market for TRAQ is over $60 billion.
Proven Technology, Team, and Market: TRAQ has been tested and validated both in the lab (3 Clinical Trials and counting) and in the market (Tokyo Olympics, USA Cycling, NCAA programs, Triathlons, everyday use focus groups), led by a team of experienced scientists and management.
On-Demand Information Trend: At-home, real-time, non-invasive health and wellness monitoring is in high demand.
OVERVIEW
Own Your Health
TRAQ has developed a personal hand-held device providing non-invasive saliva testing for the real-time measurement of personal fitness, health, and wellness. Initially developed for the U.S. Air Force in research labs with over $32M of government funding, TRAQ has made the leap from lab to market. Unlike most personal health trackers, TRAQ measures specific biomarkers such as glucose, cortisol, cholesterol, lactate and ketones to understand what is happening inside the body at the molecular level. Collectively, these biomarkers provide accurate feedback related to your fitness, health, and wellness quickly and safely in 30 seconds.
As our “on-demand” culture expands beyond news and entertainment, health and wellness is next – including electronic medical records, at-home diagnostic tests, telemedicine, and point-of-care tests (POCT). TRAQ provides one of the first-ever solution to providing on-demand knowledge and ownership of your health & wellness without the inconvenience, invasiveness, and expense of traditional lab tests.
TRAQ’s POCT device, called the “Stone,” uses disposable testing cartridges to provide not only test results but also actionable insights. With TRAQ’s interpreted results, you have the preparation and predictability for optimal performance in sport and activity as well as guidance for better management of personal health and wellness.
*TRAQ products are currently under development. The Traq POCT device called the "Stone" is currently available for pre-orders.
THE PROBLEM
Health Testing is Costly, Slow, and Invasive
Blood tests are typically the first step in assessing general fitness or any potential ailments, but they come with many pain points. They are expensive, costing nearly $1,500 for the uninsured in the US. Results are normally not available for days, if not weeks. Additionally, 1 in 5 people worldwide have a phobia of needles, and only half the world’s population has adequate access to healthcare.
And it’s no different for athletes – casual or elite. Measuring fitness and performance still requires the same level of expense and invasive medical personnel, all with the same lengthy wait for results.
The problem is real and significant.
THE SOLUTION
Simple & Easy Testing in Real Time
All health and wellness biomarkers present in your blood (glucose, cortisol, cholesterol, insulin, etc.) are also present in your saliva. TRAQ has developed a proprietary, non-invasive, on demand, point-of-care (POCT) device, called the “Stone,” which uses disposable test cartridges for collecting saliva samples. When test cartridges are inserted into the Stone, biomarker concentrations are converted into digital information providing analyzed results in real time on the Stone’s display or a smart device via the TRAQ app. The test takes less than 30 seconds and uses a simple 5-step process.
*TRAQ products are currently under development. The Traq POCT device called the "Stone" is currently available for pre-orders.
THE MARKET
$60 Billion and Growing
There is an increasing market need for on-demand and convenient services in healthcare and fitness. This is seen in the growth of at-home testing, telemedicine, personalized medicine, and in-home gyms. The total addressable market for TRAQ is over $60 billion. Markets with addressable problems include fitness and lifestyle ($1.3B), at-home testing for Dr. Moms ($29B), workplace demand for drug screening/compliance or corporate wellness programs ($7.1B), and clinical uses for rapid, remote, digital or telemedicine ($22.4B).
*TRAQ products are currently under development. The Traq POCT device called the "Stone" is currently available for pre-orders.
Entry into these market segments will allow TRAQ to expand beyond current product offerings, taking even further advantage of the personalized or bespoke healthcare trends, for example, gender-based tests for women’s and men’s health or one-to-one cartridges for “John Doe” that might measure heart health and energy levels. Further, the Livestock & Pet markets are viable but untapped markets.
Our long-term revenue will come from product sales, subscription-based test cartridges, anonymized data sales, and actionable insights through ad revenue. Additionally, cross-promotional and targeted retailers for co-branding launches will provide extended revenue streams.
*The above listed revenue streams are some of the possible future revenue sources. TRAQ products are currently under development. The Traq POCT device called the "Stone" is currently available for pre-orders.
Sources: PRNewswire, Verified Market Research, Grandview Research, KSU Sentinel, Grandview Research
OUR TRACTION
Clinical Trials, Olympian Tested
TRAQ’s “lab in a pocket,” handheld POCT device – “the Stone” – provides both high level, detailed fitness, health and wellness information in real-time. Three clinical trials had been successfully completed (Energy, Recovery, Hydration), with more on the horizon. The U.S. Cycling team adopted TRAQ as part of its preparation and training for the Tokyo Olympics. Broader use of TRAQ in the US Olympics and Paralympics has also taken place (boxing, rugby, wrestling athletes), as well as for NCAA Division I teams and sponsored triathletes.
Former cycling gold medalist and current Director of USA Cycling, Jamie Staff, believes in TRAQ not only for his Olympic athletes, but also for the casual athlete, as well as the ability to help anyone measure and monitor their general health and wellness.
“As a former Olympian, current coach and just someone that cares about my health and staying in shape, I feel it’s important to know what’s going on INSIDE my body. Both myself and my athletes want to truly OWN our own health.
“TRAQ provides in-depth information about my fitness and health – in real-time, using only saliva – so it’s non-invasive, and each test only costs a few dollars. Plus, I don’t need any doctors or technicians. Anyone can do these tests. Energy. Hydration. Nutrition. Any fitness or health & wellness category.
“It’s the perfect fitness and health tracker - for me now, as the casual athlete as well as for my athletes training to compete at the highest levels, trying to squeeze out every bit of performance possible.
Now, we can truly own our own health.”
- Jaime Staff, Former Olympic Gold-winning Cyclist & Current Director of US Cycling
WHY INVEST
The Future of Healthcare
In five years, we envision TRAQ not only as the everyday tool for all athletes and fitness enthusiasts, but also as an easier entry into the healthcare system. Individuals and families will be able to track and monitor their own health and wellness without the anxiety, cost, or hassle of traditional testing, sharing data with health professionals only as necessary.
TRAQ is the future of personalized fitness, health and wellness monitoring.
Own Your Health.™
*TRAQ products are currently under development. The Traq POCT device called the "Stone" is currently available for pre-orders.
ABOUT
HEADQUARTERS
1930 Kellogg Avenue
Carlsbad, CA 92008
WEBSITE
View Site
TRAQ has developed a non-invasive fitness, health & wellness “lab in a pocket” device. Addressing the growing concern of expensive, invasive and often slow testing in today’s current reality, TRAQ uses saliva to accurately measure both specific and general health & wellness categories (energy, nutrition, hydration, fitness, stress, sleep, heart health and many more) safely in 30 seconds, proving the future of health and wellness is here.
TEAM
Dr. Joseph Wang
Co-Founder & Consultant
The advances made by Dr. Wang have been described in over 1,200 research papers and reviews, that were cited over 135,000 times, leading to a H Index of 181.
Education: Technion (BSc, MSc, PhD Chemistry), University of Wisconsin, Madison (post doctoral research associate). Joseph is a part-time consultant.
Dr. Patrick Mercier
Co-Founder & Consultant
Patrick is currently an Associate Professor in Electrical and Computer Engineering at the University of California San Diego (UCSD), where he is also the co-Director of the Center for Wearable Sensors. His research interests include the design of energy-efficient microsystems, focusing on the design of RF circuits, power converters, and sensor interfaces for miniaturized systems and biomedical applications.
Education: University of Alberta (BSc EECS), MIT (MSc, PhD EECS). Dr. Mercier is a part-time consultant.
Jeff Slosar
CEO
Previous positions: NextWave Ventures, NASA, Triniti (Sony, Qualcomm, Allied Signal), PRTM.
Education: University of Michigan (BSc Engineering Physics, MSc Biomedical Engineering), MBA (INSEAD, France).
Dr. Santhosh Padmanabhan
Director, Research & Development
Santhosh has over 15 years experience specializing specifically in point of care devices and IVD technologies. He is the author of over 65 research publications and holder of 5 patents.
Previous positions: Technological University Dublin (Ireland), University of Pittsburgh, University of California-San Diego, Max-Planck-Institute for Solid State Research (Germany), Kyungpook National University (South Korea).
Education: Alagappa University, India (PhD Industrial Chemistry), Bharathidasan University, India (MSc Chemistry).
Thomas Cho
Lead R&D Engineer, Clinical Trials
Thomas is driven to identify and solve problems effectively and efficiently with experience and knowledge in medical device development, clinical trials, and various laboratory procedures. During his Masters degree program at University of California San Diego, he studied in Co-Founder Dr. Wang's Laboratory of Nano-BioElectronics, where TRAQ's technology stems.
Education: University of California San Diego (BSc Bioengineering, MSc Chemical Engineering).
Robert Feeney
Advisor
Rob is an experienced successful serial entrepreneur having been part of the formation, growth and exit of 3 disruptive and successful healthcare technology enabled businesses including 30+ VC/PE and IPO transactions.
Rob most recently founded Medvantx, raising over $100M and growing it to become the largest independent pharmacy / direct to patient platform in US (over $7.5B annually), serving 5 of the top 10 global pharmaceutical companies. Medvantx was acquired in a private equity sale in 2019.
Dave Sheehan
Advisor
Dave is the CEO of Nucleus BIologics, a leader in precision cell culture, providing custom cell culture products and services to expedite the time from scientific discovery to cure.
Previous positions: Cloudbreak Capital (Principal), Volcano Corp (COO, NASDAQ: VOLC, acquired by Philips), Digirad (CEO, NASDAQ: DRAD, acquired by Star Equity).
TERMS
TRAQ
Overview
PRICE PER SHARE
$14.49
DEADLINE
Feb 17, 2022
VALUATION
$33.62M
AMOUNT RAISED
$327,225.98
Breakdown
MIN INVESTMENT
$362.25
MAX INVESTMENT
$299,986.47
MIN NUMBER OF SHARES OFFERED
690
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Non-Voting Common
MAX NUMBER OF SHARES OFFERED
36,922
Maximum Number of Shares Offered subject to adjustment for bonus shares
Company | : | TRAQ, Inc. |
Corporate Address | : | 1930 Kellogg Avenue, Carlsbad, CA 92008 |
Offering Minimum | : | $9,998.10 |
Offering Maximum | : | $534,999.78 |
Minimum Investment Amount(per investor) | : | $362.25 |
Terms
Offering Type | : | Equity |
Security Name | : | Non-Voting Common |
Minimum Number of Shares Offered | : | 690 |
Maximum Number of Shares Offered | : | 36,922 |
Price per Share | : | $14.49 |
Pre-Money Valuation | : | $33,620,131.64 |
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives and Bonuses*
TIME BASED
Super Early Bird
Invest $367+ in the first 72 hours and receive 6% bonus shares
Early Bird
Invest $367+ in first 6 days and receive 3% bonus shares
VOLUME BASED
∙ Tier 1 - $1,500
Invest $1,500+ and receive 1% bonus shares + FREE Shirt or Bottle
∙ Tier 2 - $2,500
Invest $2,500+ and receive 3% bonus shares + FREE Shirt or Bottle + USER tester (can be part of beta testing)
∙ Tier 3 - $5,000
Invest $5,000+ and receive 4% bonus shares + FREE Shirt or Bottle + 50% of Stone (TRAQ DEVICE) + 50 free cartridges + USER TESTER
∙ Tier 4 - $10,000
Invest $10,000+ and receive 6% bonus shares + FREE Shirt or Bottle + FREE Stone + 2-month Cartridge subscription (100 cartridges) + USER TESTER
∙ Tier 5 - $25,000
Invest $25,000+ and receive 8% bonus shares + FREE Shirt or Bottle + FREE Stone + 6-month cartridge subscription (300 cartridges)+ USER TESTER
*All perks occur when the offering is completed and product is available.
The 10% StartEngine Owners' Bonus
TRAQ, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Non-Voting Common Stock at $14.49 / share, you will receive 110 Non-Voting Common Stock, meaning you'll own 110 shares for $1449. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are cancelled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.
ALL UPDATES
02.07.22
Notice of Funds Disbursement
[The following is an automated notice from the StartEngine team].
Hello!
As you might know, TRAQ has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in TRAQ be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
12.14.21
Notice of Funds Disbursement
[The following is an automated notice from the StartEngine team].
Hello!
As you might know, TRAQ has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in TRAQ be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
12.09.21
Pet Health Too ?!
After all, we’re all mammals.
TRAQ’s saliva-based health & wellness device can also be used for your pet's health. Check out a field test using one of our sensors retro-fitted into a dog toy.
TRAQ can detect salivary biomarkers regardless the animal. Think pets, livestock.
- TRAQ Team
12.01.21
Working with USA Olympic Teams
TRAQ is continuing its work with US Olympic Teams. Starting back in July 2021, TRAQ started working with various USA BMX cyclists as they ramped up for the Tokyo Olympics. TRAQ measured athlete's Energy and Hydration levels in real-time, before and after their races, to help them find an edge. With that data in hand, pre-race preparations were altered to optimize their performance.
Word spread about TRAQ's capabilities and benefits within USOPC - no blood, real-time, accurate.
Recently, we expanded our efforts with USA Volleyball and USA Boxing. Athletes looking to fine tune their performances, accelerate recovery, and optimize their preparation are using TRAQ. Actionable insights include changes to training regimens and nutrition, mid-event recovery, and better customized energy drinks during timeouts or between boxing rounds.
But TRAQ is not just for elite athletes like US Olympians. It's for anyone looking to gain better insight into their health. Why not own your health?
More soon.
- TRAQ Team
11.23.21
Welcome to TRAQs OPO on StartEngine
Hi All,
It took a lot of really nerdy tech and hard work to get to this point, but clinical trials are done and TRAQ is ready for the market!
What is TRAQ?
A portable (handheld) fitness, health & wellness device - truly non-invasive diagnostics – no doctors, no needles, no blood. Just saliva. Biomarkers (like lactate, glucose, testosterone, etc.) are measured in your saliva, giving you results in seconds to minutes. We’re already working with many US Olympics teams. First, there was cycling, then volleyball, now we’re on the acrobatics and combat sports. Beyond the Olympics, we’re just starting to work with NCAA Division 1 athletic programs. But, it’s not just for athletes.
Your investment will help us start formal production for the Energy and Hydration sensors, with Nutrition, Burn and Recovery sensors to follow. The demand is there, we just need help satisfying it.
The pandemic’s been hard on everyone, but one benefit from our perspective is how educated the market has become regarding non-invasive ways of measuring our health. We don’t need blood. Not even nasal swabs. Saliva is perfect.
Thanks to everyone who's supporting our campaign and our mission toward personalized healthcare for everyone. Feel free to reach out with ANY questions. We mean it.
- TRAQ Team
REWARDS
$362
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$1,500
Tier 1 - $1,500+
Invest $1,500+ and receive 1% bonus shares + FREE Shirt or Bottle
$2,500
Tier 2 - $2,500+
Invest $2,500+ and receive 3% bonus shares + FREE Shirt or Bottle + USER tester (can be part of beta testing)
$5,000
Tier 3 - $5,000+
Invest $5,000+ and receive 4% bonus shares + FREE Shirt or Bottle + 50% of Stone (TRAQ DEVICE) + 50 free cartridges + USER TESTER
$10,000
Tier 4 - $10,000+
Invest $10,000+ and receive 6% bonus shares + FREE Shirt or Bottle + FREE Stone + 2-month Cartridge subscription (100 cartridges) + USER TESTER
$25,000
Tier 5 - $25,000+
Invest $25,000+ and receive 8% bonus shares + FREE Shirt or Bottle + FREE Stone + 6-month cartridge subscription (300 cartridges)+ USER TESTER
JOIN THE DISCUSSION
0/2500
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
